Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash from Investing Activities (2016 - 2026)

Collegium Pharmaceutical has reported Cash from Investing Activities over the past 10 years, most recently at -$20.1 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 70.63% year-over-year to -$20.1 million; the TTM value through Dec 2025 reached -$63.5 million, up 77.92%, while the annual FY2025 figure was -$63.5 million, 77.92% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$20.1 million at Collegium Pharmaceutical, up from -$30.9 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$113000.0 in Q3 2022 and troughed at -$572.2 million in Q1 2022.
  • A 5-year average of -$49.9 million and a median of -$6.4 million in 2023 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 133586.21% in 2022 and later soared 99.97% in 2023.
  • Year by year, Cash from Investing Activities stood at -$515000.0 in 2021, then tumbled by 82.52% to -$940000.0 in 2022, then tumbled by 2569.89% to -$25.1 million in 2023, then skyrocketed by 53.13% to -$11.8 million in 2024, then tumbled by 70.63% to -$20.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for COLL at -$20.1 million in Q4 2025, -$30.9 million in Q3 2025, and -$2.9 million in Q2 2025.